A treatment planning study of the potential of geometrical tracking for intensity modulated proton therapy of lung cancer

References

• WHO (February 2006). “Cancer”. Lyon: World Health Organization; 2010.
   Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581–92.
   PubMed Web of Science ®Google Scholar
• Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): A systematic review. Thorax 2001;56:628–38.
   PubMed Web of Science ®Google Scholar
• van Rens MT, de la Riviere AB, Elbers HR, van den Bosch JM. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000;117:374–9.
   PubMed Web of Science ®Google Scholar
• Belderbos JS, Heemsbergen WD, De JK, Baas P, Lebesque JV. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006;66: 126–34.
   PubMed Web of Science ®Google Scholar
• Dosoretz DE, Katin MJ, Blitzer PH, Rubenstein JH, Galmarini DH, Garton GR, . Medically inoperable lung carcinoma: The role of radiation therapy. Semin Radiat Oncol 1996;6:98–104.
   PubMed Web of Science ®Google Scholar
• Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 1998;40:149–54.
   PubMed Web of Science ®Google Scholar
• Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, . Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2005;61: 318–28.
   PubMed Web of Science ®Google Scholar
• Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, . Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006;66:1399–407.
   PubMed Web of Science ®Google Scholar
• Lomax AJ. Charged particle therapy: The physics of interaction. Cancer J 2009;15:285–91.
   PubMed Web of Science ®Google Scholar
• Turesson I, Johansson KA, Mattsson S. The potential of proton and light ion beams in radiotherapy. Acta Oncol 2003;42:107–14.
   PubMed Web of Science ®Google Scholar
• Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol 1999;44:185–205.
   PubMed Web of Science ®Google Scholar
• Zurlo A, Lomax A, Hoess A, Bortfeld T, Russo M, Goitein G, . The role of proton therapy in the treatment of large irradiation volumes: A comparative planning study of pancreatic and biliary tumors. Int J Radiat Oncol Biol Phys 2000;48:277–88.
   PubMed Web of Science ®Google Scholar
• Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, . Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;65:1087–96.
   PubMed Web of Science ®Google Scholar
• Georg D, Hillbrand M, Stock M, Dieckmann K, Potter R. Can protons improve SBRT for lung lesions? Dosimetric considerations. Radiother Oncol 2008;88:368–75.
   PubMed Web of Science ®Google Scholar
• Grutters JP, Kessels AG, Pijls-Johannesma M, De RD, Joore MA, Lambin P. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysis. Radiother Oncol 2010;95:32–40.
   PubMed Web of Science ®Google Scholar
• Pijls-Johannesma M, Grutters JP, Lambin P, Ruysscher DD. Particle therapy in lung cancer: Where do we stand? Cancer Treat Rev 2008;34:259–67.
   PubMed Web of Science ®Google Scholar
• Widesott L, Amichetti M, Schwarz M. Proton therapy in lung cancer: Clinical outcomes and technical issues. A systematic review. Radiother Oncol 2008;86:154–64.
   PubMed Web of Science ®Google Scholar
• van de WS, Kreuger R, Zenklusen S, Hug E, Lomax AJ. Tumour tracking with scanned proton beams: Assessing the accuracy and practicalities. Phys Med Biol 2009;54: 6549–63.
   PubMed Web of Science ®Google Scholar
• Seco J, Robertson D, Trofimov A, Paganetti H. Breathing interplay effects during proton beam scanning: Simulation and statistical analysis. Phys Med Biol 2009;54: N283–N294.
   PubMed Web of Science ®Google Scholar
• Paganetti H, Jiang H, Trofimov A. 4D Monte Carlo simulation of proton beam scanning: Modelling of variations in time and space to study the interplay between scanning pattern and time-dependent patient geometry. Phys Med Biol 2005;50:983–90.
   PubMed Web of Science ®Google Scholar
• Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: The potential effects of inter-fraction and inter-field motions. Phys Med Biol 2008;53:1043–56.
   PubMed Web of Science ®Google Scholar
• Kang Y, Zhang X, Chang JY, Wang H, Wei X, Liao Z, . 4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys 2007;67:906–14.
   PubMed Web of Science ®Google Scholar
• Hui Z, Zhang X, Starkschall G, Li Y, Mohan R, Komaki R, . Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys 2008;72:1385–95.
   PubMed Web of Science ®Google Scholar
• Engelsman M, Rietzel E, Kooy HM. Four-dimensional proton treatment planning for lung tumors. Int J Radiat Oncol Biol Phys 2006;64:1589–95.
   PubMed Web of Science ®Google Scholar
• Zhao L, Sandison GA, Farr JB, Hsi WC, Li XA. Dosimetric impact of intrafraction motion for compensator-based proton therapy of lung cancer. Phys Med Biol 2008;53: 3343–64.
   PubMed Web of Science ®Google Scholar
• Lawson JD, Schreibmann E, Jani AB, Fox T. Quantitative evaluation of a cone-beam computed tomography-planning computed tomography deformable image registration method for adaptive radiation therapy. J Appl Clin Med Phys 2007;8:96–113.
   PubMed Web of Science ®Google Scholar
• Schreibmann E, Thorndyke B, Li T, Wang J, Xing L. Four-dimensional image registration for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2008;71:578–86.
   PubMed Web of Science ®Google Scholar
• Mattes D, Haynor DR, Vesselle H, Lewellen TK, Eubank W. PET-CT image registration in the chest using free-form deformations. IEEE Trans Med Imaging 2003;22:120–8.
   PubMed Web of Science ®Google Scholar
• Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, . Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010;76:S70–S76.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Nakagawa K, Nakamura N, Koyanagi H, Tago M, Igaki H, . Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2007;2:1–11.
   PubMed Web of Science ®Google Scholar
• Lambert J, Suchowerska N, McKenzie DR, Jackson M. Intrafractional motion during proton beam scanning. Phys Med Biol 2005;50:4853–62.
   PubMed Web of Science ®Google Scholar
• Falk M, Munck af Rosenschold P, Keall P, Cattell H, Cho BC, Poulsen P, . Real-time dynamic MLC tracking for inversely optimized arc radiotherapy. Radiother Oncol 2010;94:218–23.
   PubMed Web of Science ®Google Scholar
• Sonke JJ, Belderbos J. Adaptive radiotherapy for lung cancer. Semin Radiat Oncol 2010;20:94–106.
   PubMed Web of Science ®Google Scholar